FdaApplication

BLA 125685

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSumitomo Pharma America, Inc.
application_typeBLA
approval_date2021-10-08

Products (1)

ProductActive ingredientStrengthDosage form
RETHYMIC—SEMI-QUANTITATIVEFor Suspension

1 product